Financials

News Ideas Discussions Technicals Forecast Seasonals

CSBTF fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to Kuros Bioscience Ltd. operating, investing, and financing activities

CSBTF free cash flow for H1 24 is -1.02 M USD. For 2023, CSBTF free cash flow was -10.88 M USD and operating cash flow was -10.5 M USD.

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: USD

TTM

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—